Qube Research & Technologies (QRT)
NMRA icon

Qube Research & Technologies (QRT)’s Neumora Therapeutics NMRA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.7K Sell
25,093
-172,270
-87% -$328K ﹤0.01% 3147
2026
Q1 		$385K Buy
+197,363
New +$511K ﹤0.01% 2808
2024
Q2 		– Sell
-18,242
Closed -$251K – 4443
2024
Q1 		$251K Buy
+18,242
New +$295K ﹤0.01% 2915
2023
Q4 		– Sell
-21,400
Closed -$302K – 4609
2023
Q3 		$302K Buy
+21,400
New +$267K ﹤0.01% 2243

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NMRA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Neumora Therapeutics (NMRA) stake by 87% in Q2 2026, selling an estimated $328K and leaving 25,093 shares worth $42.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3147.

Qube Research & Technologies (QRT) first reported a position in NMRA in Q3 2023 and has held it in 4 quarters since. The position peaked at $385K in Q1 2026. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Qube Research & Technologies (QRT) held 25,093 shares of Neumora Therapeutics worth $42.7K as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 172,270 Neumora Therapeutics shares in Q2 2026, an estimated $328K.
  • Neumora Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3147 holding.
  • Qube Research & Technologies (QRT) first reported a position in Neumora Therapeutics in Q3 2023 and has held it in 4 quarters since.
  • Qube Research & Technologies (QRT)'s Neumora Therapeutics position peaked at $385K in Q1 2026.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.